California State Teachers Retirement System (CalSTRS)
NRIX icon

California State Teachers Retirement System (CalSTRS)’s Nurix Therapeutics NRIX Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68M Sell
69,327
-29,715
-30% -$506K ﹤0.01% 1676
2026
Q1 		$1.54M Buy
99,042
+31,023
+46% +$514K ﹤0.01% 1665
2025
Q4 		$1.29M Buy
68,019
+1,476
+2% +$21.2K ﹤0.01% 1672
2025
Q3 		$615K Sell
66,543
-451
-0.7% -$4.68K ﹤0.01% 2000
2025
Q2 		$763K Hold
66,994
– – ﹤0.01% 1870
2025
Q1 		$796K Buy
66,994
+14,663
+28% +$245K ﹤0.01% 1820
2024
Q4 		$986K Sell
52,331
-123
-0.2% -$2.82K ﹤0.01% 1785
2024
Q3 		$1.18M Buy
52,454
+2,480
+5% +$56.2K ﹤0.01% 1689
2024
Q2 		$1.04M Buy
49,974
+45,188
+944% +$704K ﹤0.01% 1733
2024
Q1 		$70.4K Sell
4,786
-3,049
-39% -$32.8K ﹤0.01% 2476
2023
Q4 		$80.9K Sell
7,835
-36,750
-82% -$252K ﹤0.01% 2508
2023
Q3 		$350K Sell
44,585
-6,476
-13% -$59.1K ﹤0.01% 2358
2023
Q2 		$510K Buy
51,061
+2,746
+6% +$28K ﹤0.01% 2295
2023
Q1 		$429K Sell
48,315
-846
-2% -$8.82K ﹤0.01% 2371
2022
Q4 		$540K Buy
49,161
+1,838
+4% +$22.2K ﹤0.01% 2302
2022
Q3 		$617K Buy
47,323
+77
+0.2% +$1.22K ﹤0.01% 2233
2022
Q2 		$599K Buy
47,246
+16,874
+56% +$191K ﹤0.01% 2288
2022
Q1 		$426K Sell
30,372
-3,427
-10% -$60.8K ﹤0.01% 2453
2021
Q4 		$978K Buy
33,799
+487
+1% +$14.8K ﹤0.01% 2176
2021
Q3 		$998K Sell
33,312
-9,876
-23% -$305K ﹤0.01% 2148
2021
Q2 		$1.15M Buy
43,188
+7,077
+20% +$208K ﹤0.01% 2122
2021
Q1 		$1.12M Buy
36,111
+18,491
+105% +$700K ﹤0.01% 2077
2020
Q4 		$579K Buy
17,620
+815
+5% +$27K ﹤0.01% 2347
2020
Q3 		$587K Buy
+16,805
New +$424K ﹤0.01% 2183

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

California State Teachers Retirement System (CalSTRS)'s NRIX Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Nurix Therapeutics (NRIX) stake by 30% in Q2 2026, selling an estimated $506K and leaving 69,327 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1676.

California State Teachers Retirement System (CalSTRS) first reported a position in NRIX in Q3 2020 and has held it in 24 quarters since. 211 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 69,327 shares of Nurix Therapeutics worth $1.68M as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) sold 29,715 Nurix Therapeutics shares in Q2 2026, an estimated $506K.
  • Nurix Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #1676 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Nurix Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • 211 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.